Maravai Lifesciences Holdings MRVI Ratios (2020-2026)

NASDAQ MRVI
$7.32 -0.05 (-0.68%)
At close: Sep 4, 2026 · 4:00 PM EDT
Reported Financials

Maravai Lifesciences Holdings Quarterly Ratios

Periods 26 quarters
Latest Jun 2026

Maravai Lifesciences Holdings reported a gross margin of 40.14% and a net margin of -42.05% for the quarter ended Jun 2026. These financial ratios cover 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
84.27%82.87%83.61%84.55%80.04%73.99%57.39%37.21%45.13%52.65%40.27%44.42%46.70%34.28%16.49%16.39%13.58%25.75%51.19%40.14%
EBT Margin
73.74%63.34%68.30%72.09%59.48%46.83%-5.72%-19.39%-30.75%885.05%-34.92%-30.04%-249.39%-81.46%-112.47%-156.39%-108.45%-126.36%-9.92%-42.38%
EBIT Margin
75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%-117.91%-3.28%-29.33%
EBITDA Margin
75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%-117.91%-3.28%-29.33%
Operating Margin
75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%-117.91%-3.28%-29.33%
Net Margin
64.54%55.64%60.12%64.57%52.10%42.71%-1.71%-17.33%-22.59%-148.34%-35.34%-26.53%-249.84%-81.45%-112.81%-147.34%-108.23%-126.37%-9.69%-42.05%
FCF Margin
50.89%23.24%65.31%66.99%54.16%45.49%97.70%-8.51%-2.48%-12.15%-22.02%11.35%6.58%-36.22%-29.65%-27.72%-45.18%-49.90%6.42%7.04%
Efficiency
Inventory AverageInventory Avg.
0.05B0.05B0.05B0.06B0.06B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.05B0.04B0.04B0.04B
Assets AverageAssets Avg.
1.75B1.91B1.98B2.11B2.21B2.27B2.30B2.29B2.27B1.88B1.47B1.44B1.36B1.14B0.98B0.93B0.87B0.81B0.74B0.66B
Invested CapitalInvested Cap.
1.21B1.30B1.41B1.53B1.59B1.48B1.63B1.43B1.42B1.32B1.31B1.30B1.13B0.88B0.83B0.77B0.73B0.67B0.62B0.50B
Asset Utilization RatioAsset Util.
0.380.420.450.440.410.390.310.240.190.150.190.190.200.230.250.240.220.230.280.32
Leverage & Solvency
Interest Coverage RatioInterest Cover
20.2222.0162.8340.7537.2810.730.21-1.65-1.32-0.46-1.74-1.13-12.15-3.35-7.25-9.73-6.00-8.97-0.38-3.14
Debt Ratio
0.400.390.370.350.330.250.310.230.230.360.370.360.410.300.310.330.350.390.350.25
Times Interest Earned
20.2222.0162.8340.7537.2810.730.21-1.65-1.32-0.46-1.74-1.13-12.15-3.35-7.25-9.73-6.00-8.97-0.38-3.14
Dividends & Payouts
Dividend Coverage RatioDiv. Cover
2.641.163.683.682.712.83-0.16-9.15-32.20590.60
FCF Payout RatioFCF Cover
0.482.070.250.260.360.330.11-0.220.070.00
Dividend YieldDiv. Yield
0.40%1.03%0.44%0.59%0.56%0.85%0.24%0.04%0.03%-0.01%
Payout Ratio
0.380.870.270.270.370.35-6.16-0.11-0.030.00
Valuation
Price to EarningsP/E
95.6984.1161.2946.2665.3841.80-0.00B-261.23-166.23-14.97-96.24-98.05-12.16-30.09-10.65-8.81-16.27-13.20-114.58-74.91
Price to SalesP/S
61.7546.8036.8529.8734.0717.8544.5045.2737.5422.2034.0126.0130.3724.5112.0112.9817.6116.6911.1031.50
Price to BookP/B
27.6619.6013.769.377.744.043.903.482.812.082.812.343.422.401.061.311.702.231.984.56
Enterprise Value
12.80B10.92B9.27B7.57B6.85B3.38B3.90B2.92B2.30B1.44B1.99B1.56B1.79B1.31B0.51B0.55B0.68B0.78B0.72B1.70B
EV to EBIT
82.3870.6755.4041.8858.6230.960.00B-251.14-149.43-202.00-105.39-116.37-10.78-34.86-10.32-8.26-16.47-13.19-334.68-112.75
EV to EBITDA
82.3870.6755.4041.8858.6230.960.00B-251.14-149.43-202.00-105.39-116.37-10.78-34.86-10.32-8.26-16.47-13.19-334.68-112.75
Market Capitalization
12.65B10.69B9.00B7.25B6.52B3.65B3.52B3.12B2.51B1.65B2.18B1.81B2.10B1.39B0.56B0.62B0.73B0.83B0.73B1.62B
Price to FCFP/FCF
121.34201.3956.4144.5962.9039.2445.54-531.95-0.00B-182.72-154.45229.16461.25-67.66-40.52-46.83-38.97-33.44172.81447.37
EV to FCF
122.81205.7258.1246.5466.1636.3250.45-497.32-0.00B-160.32-140.65198.46392.97-64.15-36.53-41.67-35.93-31.17170.82469.70
EV to CFO
121.26185.9157.1346.0762.2734.0545.79151.96162.63185.41-234.7689.71135.96-89.79-54.04-53.34-44.61-34.0683.35426.16
Return Ratios
Return on Sales [ROS]ROS
75.87%67.65%68.51%74.44%61.12%53.37%3.21%-16.85%-23.06%-9.64%-29.39%-19.36%-239.93%-66.66%-104.93%-139.84%-98.56%-117.91%-3.28%-29.33%
Return on Capital Employed [ROCE]ROCE
26.40%30.60%33.30%32.98%29.58%26.64%18.83%9.80%3.87%-1.77%-3.77%-3.99%-15.81%-21.69%-28.88%-37.12%-23.93%-28.14%-24.06%-18.88%
Return on Invested Capital [ROIC]ROIC
36.79%39.10%41.44%39.64%35.10%33.25%23.75%12.88%6.11%0.52%1.08%1.18%12.39%-23.24%-30.91%-39.45%-25.43%-30.20%-25.55%-20.86%
Return on Assets [ROA]ROA
20.40%24.61%27.29%26.71%23.99%21.66%14.90%7.59%2.61%-7.37%-10.89%-11.51%-23.77%-22.71%-29.45%-36.75%-24.49%-28.49%-24.84%-20.67%